CFDE Data Portal | Search GTSE1

	Label	Description
	GTSE1 Gene (Entity type)	ENSG00000075218 - G2 and S-phase expressed 1
	GTSE1 associations Collection (Entity type)	Associations for GTSE1_associations
	GTSE1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GTSE1-AS1 associations Collection (Entity type)	Associations for GTSE1-AS1_associations
	GTSE1-AS1 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	GTSE1-DT Gene (Entity type)	ENSG00000277232 - GTSE1 divergent transcript
	GSE166914 1 V 2 ABEMACICLIB HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 14 V 13 NICOTINAMIDE HUMAN DN Gene Set (Entity type)	A Gene Set from LINCS
	GSE252944 AKT inhibition 10 v 15 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE218773 ABL2 knockdown Hep-G2 2 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS

GTSE1

ENSG00000075218 - G2 and S-phase expressed 1

GTSE1 associations

Associations for GTSE1_associations

GTSE1 associations.tsv

A file from IDG as part of the Harmonizome project

GTSE1-AS1 associations

Associations for GTSE1-AS1_associations

GTSE1-AS1 associations.tsv

A file from IDG as part of the Harmonizome project

GTSE1-DT

ENSG00000277232 - GTSE1 divergent transcript

GSE166914 1 V 2 ABEMACICLIB HUMAN DN

A Gene Set from LINCS

GSE233679 14 V 13 NICOTINAMIDE HUMAN DN

A Gene Set from LINCS

GSE252944 AKT inhibition 10 v 15 human dn

A Gene Set from LINCS

GSE218773 ABL2 knockdown Hep-G2 2 v 0 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.